Profitability Metrics

Gross Margin
27.27%
Operating Margin
24.29%
Net Margin
8.03%

Efficiency Metrics

Revenue per Expense Ratio
1.32
R&D as % of Revenue
0.00%

Earnings Quality

EBITDA Margin
24.50%
Income Tax Rate
0.36%
EPS
0.3600000000

Balance Sheet Analysis

Current Ratio
1.04
Cash Ratio
0.41
Working Capital
$12.03M
Debt to Equity
0.79
Debt to Assets
39.83%
Equity Ratio
50.70%

Cash Flow Analysis

Operating Cash Flow Ratio
22.10%
Free Cash Flow Ratio
11.03%
CapEx to Revenue
11.07%
Dividends Paid
$41.73M
Stock Buybacks
$5.46M
Total Shareholder Returns
$47.18M
Cash Position Change
55.98%

Key Takeaways (2023 FY)

  • Increased dividend payments by 158.06%

Detailed Growth Metrics

Core Performance

Revenue
7.33%
Net Income
-21.03%
EPS
-23.40%
Operating Income
59.08%

Operational Efficiency

R&D Expenses
-100.00%
SG&A Expenses
-41.97%
Operating Cash Flow
15.19%
Free Cash Flow
373.41%

Balance Sheet Health

Assets
0.97%
Debt
-0.52%
Book Value per Share
3.75%
Inventory
0.00%

Shareholder Returns

Dividends per Share
158.06%
Shares Outstanding
-0.43%

Long Term Trends

3Y Revenue/Share
242.19%
5Y Revenue/Share
20.89%
3Y Dividend/Share
37.86%
5Y Dividend/Share
-60.54%